November 22, 2019 Porzio's Family of Companies Receive Community Impact Award Barbara DeMarco Lynn Nowak Jacy Lance Sal Anderton
January 12, 2021 – February 2, 2021 PLS Webinar Series “The Department of Justice is Watching: Building a Data-Driven Compliance Program” Michael O'Connor Isha Arora Theodore Rosini
May 19, 2020 – May 21, 2020 PCC Webcast Series - Pharmaceutical Compliance Digital Week John Oroho Michael O'Connor Chrissy Bradshaw
February 10, 2020 – February 12, 2020 CBI Informa Connect's 8th Annual Compliance Monitoring, Audit & Risk Oversight John Oroho Michael O'Connor Jennifer Romanski
November 20, 2020 Pharmaceutical Executive The Department of Justice is Watching: Building a Data-Driven Compliance Program
November 3, 2020 Device Company Settles Open Payment Program Reporting Violation, Agrees to Pay Over $9.2 Million
November 2, 2020 FDA Clarifies Types of Evidence Relevant to Determining the "Intended Use" of a Product
July 31, 2017 New and Evolving Requirements for Pharmaceutical Representatives: Chicago, Nevada and Others Chrissy Bradshaw
March 23, 2016 HCP Payments Transparency Outside of the US: An Evolving Complex Environment with Implications for Medical Device Companies
March 3, 2016 Transparency Going Global: How Reporting in the US Matches Up to the O-US Reporting Regime Chrissy Bradshaw
January 20, 2015 2014 Highlights for Promotional Review Professionals: FDA Enforcement and Guidance Jennifer Romanski